| scholarly article | Q13442814 |
| P50 | author | Joseph DeSimone | Q6282541 |
| Stefan W Metz | Q61078454 | ||
| Aravinda M. de Silva | Q89242260 | ||
| Shaomin Tian | Q93015620 | ||
| Katie Horvath | Q125314569 | ||
| Alex Brackbill | Q125314691 | ||
| P2093 | author name string | Michael J Miley | |
| Chris Luft | |||
| Ashlie Thomas | |||
| Michele Stone | |||
| Yi Xianwen | |||
| P2860 | cites work | The global distribution and burden of dengue | Q24628768 |
| From research to phase III: preclinical, industrial and clinical development of the Sanofi Pasteur tetravalent dengue vaccine | Q24737418 | ||
| Dengue Virus Envelope Dimer Epitope Monoclonal Antibodies Isolated from Dengue Patients Are Protective against Zika Virus | Q26247258 | ||
| The Complexity of a Dengue Vaccine: A Review of the Human Antibody Response | Q26995782 | ||
| A Tetravalent Sub-unit Dengue Vaccine Formulated with Ionizable Cationic Lipid Nanoparticle induces Significant Immune Responses in Rodents and Non-Human Primates | Q27116692 | ||
| Comparison of Plaque- and Flow Cytometry-Based Methods for Measuring Dengue Virus Neutralization | Q27484661 | ||
| Development of a recombinant tetravalent dengue virus vaccine: Immunogenicity and efficacy studies in mice and monkeys | Q27491049 | ||
| Physiological temperatures reduce dimerization of dengue and Zika virus recombinant envelope proteins. | Q54231305 | ||
| Nanovaccinology: the next generation of vaccines meets 21st century materials science and engineering | Q87446725 | ||
| WHO recommends additional tests for Sanofi's dengue vaccine after safety concerns | Q88426591 | ||
| Neutralizing Antibody Correlates Analysis of Tetravalent Dengue Vaccine Efficacy Trials in Asia and Latin America | Q89453187 | ||
| Natural Strain Variation and Antibody Neutralization of Dengue Serotype 3 Viruses | Q27491299 | ||
| Precisely Molded Nanoparticle Displaying DENV-E Proteins Induces Robust Serotype-Specific Neutralizing Antibody Responses | Q27493140 | ||
| Structural insights into the neutralization mechanism of a higher primate antibody against dengue virus | Q27675965 | ||
| A potent anti-dengue human antibody preferentially recognizes the conformation of E protein monomers assembled on the virus surface | Q27681319 | ||
| Mapping the Human Memory B Cell and Serum Neutralizing Antibody Responses to DENV4 Infection and Vaccination | Q28114614 | ||
| The Impact of the Newly Licensed Dengue Vaccine in Endemic Countries | Q28354105 | ||
| Nanoparticles and the immune system | Q33634320 | ||
| In Vitro Assembly and Stabilization of Dengue and Zika Virus Envelope Protein Homo-Dimers | Q33867337 | ||
| Efficacy and Long-Term Safety of a Dengue Vaccine in Regions of Endemic Disease | Q34487028 | ||
| Isolation of dengue virus-specific memory B cells with live virus antigen from human subjects following natural infection reveals the presence of diverse novel functional groups of antibody clones | Q34593818 | ||
| Potent engineered PLGA nanoparticles by virtue of exceptionally high chemotherapeutic loadings | Q35064955 | ||
| Immunity in response to particulate antigen-delivery systems | Q35961146 | ||
| Identification of human neutralizing antibodies that bind to complex epitopes on dengue virions | Q35982791 | ||
| Dengue vector control strategies in an urban setting: an economic modelling assessment | Q36132072 | ||
| DENGUE VIRUS. Cryo-EM structure of an antibody that neutralizes dengue virus type 2 by locking E protein dimers | Q36352752 | ||
| Targeting dendritic cells with biomaterials: developing the next generation of vaccines | Q36627404 | ||
| Vaccine delivery: a matter of size, geometry, kinetics and molecular patterns | Q37800358 | ||
| The development of recombinant subunit envelope-based vaccines to protect against dengue virus induced disease | Q37903445 | ||
| Immune correlates of protection for dengue: State of the art and research agenda | Q38652971 | ||
| Dissecting Antibodies Induced by a Chimeric Yellow Fever-Dengue, Live-Attenuated, Tetravalent Dengue Vaccine (CYD-TDV) in Naive and Dengue-Exposed Individuals. | Q38727029 | ||
| Protective and immunological behavior of chimeric yellow fever dengue vaccine | Q38731663 | ||
| Induction of neutralizing antibodies and partial protection from viral challenge in Macaca fascicularis immunized with recombinant dengue 4 virus envelope glycoprotein expressed in Pichia pastoris. | Q39038280 | ||
| The mechanism of differential neutralization of dengue serotype 3 strains by monoclonal antibody 8A1. | Q39186657 | ||
| Functional analysis of dengue virus (DENV) type 2 envelope protein domain 3 type-specific and DENV complex-reactive critical epitope residues | Q40185205 | ||
| Purified dengue 2 virus envelope glycoprotein aggregates produced by baculovirus are immunogenic in mice | Q40622821 | ||
| Epitopic analysis of antigenic determinants on the surface of dengue-2 virions using monoclonal antibodies | Q40822411 | ||
| Antibody-enhanced dengue virus infection in primate leukocytes | Q40884212 | ||
| Adjuvant-Mediated Epitope Specificity and Enhanced Neutralizing Activity of Antibodies Targeting Dengue Virus Envelope Protein | Q41921198 | ||
| Dengue vaccine: hypotheses to understand CYD-TDV-induced protection | Q42985743 | ||
| Development of a nanoparticle-based influenza vaccine using the PRINT technology. | Q44738301 | ||
| Consider stopping dengvaxia administration without immunological screening | Q48032296 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 9 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | nanoparticle | Q61231 |
| Dengue virus | Q476209 | ||
| infectious disease | Q18123741 | ||
| P304 | page(s) | e0006793 | |
| P577 | publication date | 2018-09-01 | |
| P1433 | published in | PLoS Neglected Tropical Diseases | Q3359737 |
| P1476 | title | Nanoparticle delivery of a tetravalent E protein subunit vaccine induces balanced, type-specific neutralizing antibodies to each dengue virus serotype | |
| P478 | volume | 12 |
Search more.